Suppr超能文献

琥珀胆碱、罗库溴铵及罗库溴铵不同预充技术用于第一分钟插管条件的比较研究

Comparative study of intubating conditions at the first minute with suxamethonium, rocuronium and different priming techniques of rocuronium.

作者信息

Ortiz-Gómez J R, Carrascosa F, Pérez-Cajaraville J J, Percaz-Bados J A, Añez C

机构信息

University Clinic, Department of Anesthesiology and Intensive Care, Navarra, Spain.

出版信息

Eur J Anaesthesiol. 2005 Apr;22(4):263-8. doi: 10.1017/s026502150500044x.

Abstract

BACKGROUND AND OBJECTIVE

To evaluate orotracheal intubation conditions after 1 min.

PATIENTS AND METHODS

A prospective randomized study with 376 adult American Society of Anesthesiologists (ASA) Grade I-III patients. Each patient received propofol, fentanyl and either suxamethonium (1 mg kg(-1)) or rocuronium. The intubating dose of rocuronium (2 x ED95) was preceded 4 min earlier by saline, or a 0.1 x ED95 priming dose of rocuronium, atracurium, cis-atracurium, vecuronium or mivacurium. Intubating conditions were graded as excellent, good or poor with respect to laryngoscopy, vocal cord position and movement and reaction to intubation and/or cuff inflation.

RESULTS

There were significant differences (P < 0.05) in laryngoscopy between suxamethonium and rocuronium primed with saline, atracurium or cis-atracurium. With respect to vocal cord position and movement during intubation, rocuronium without priming differed significantly from all other groups and for reaction to insertion of tracheal tube and/or cuff inflation. Rocuronium without priming differed significantly from all other groups except for rocuronium primed with itself. The mivacurium group showed more signs of pre-curarization than other groups (P < 0.05). There were significant differences between rocuronium alone and the other groups when final intubating conditions were compared.

CONCLUSIONS

Priming rocuronium with 0.1 x ED95 of vecuronium, rocuronium, atracurium or cis-atracurium is a safe technique and did not increase risk of pre-curarization in healthy patients.

摘要

背景与目的

评估1分钟后的经口气管插管情况。

患者与方法

一项前瞻性随机研究,纳入376例美国麻醉医师协会(ASA)I - III级成年患者。每位患者均接受丙泊酚、芬太尼以及琥珀胆碱(1 mg/kg)或罗库溴铵。在给予罗库溴铵插管剂量(2×ED95)前4分钟,先给予生理盐水,或给予0.1×ED95预充剂量的罗库溴铵、阿曲库铵、顺式阿曲库铵、维库溴铵或米库氯铵。根据喉镜检查、声带位置与活动以及对插管和/或套囊充气的反应,将插管情况分为优、良或差。

结果

琥珀胆碱与用生理盐水、阿曲库铵或顺式阿曲库铵预充的罗库溴铵在喉镜检查方面存在显著差异(P < 0.05)。在插管期间声带位置与活动方面,未预充的罗库溴铵与所有其他组存在显著差异,在对气管导管插入和/或套囊充气的反应方面也如此。未预充的罗库溴铵与除自身预充的罗库溴铵外的所有其他组存在显著差异。米库氯铵组比其他组显示出更多的预箭毒化迹象(P < 0.05)。比较最终插管情况时,单用罗库溴铵与其他组之间存在显著差异。

结论

用0.1×ED95的维库溴铵、罗库溴铵、阿曲库铵或顺式阿曲库铵预充罗库溴铵是一种安全的技术,且不会增加健康患者的预箭毒化风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验